TY  - JOUR
T1  - TReatment of refractory mesial temporal lobe epilepsy
AU  - Gomez-Alonso J
Y1  - 2012/06/20
N1  - 10.1001/jama.2012.4987
JO  - JAMA
SP  - 2483
EP  - 2485
VL  - 307
IS  - 23
N2  - 
To the Editor: The efficacy of epilepsy surgery (73% seizure-free) in the best-possible surgical candidates was corroborated by Dr Engel and colleagues.1 Their trial also showed that surgery can cause irreversible deficits because a statistically reliable decline in performance on memory tests was more frequent in the surgical group (36% in delayed recall and 55% in naming) than in the medical group (0% and 7%, respectively).1 Other aspects of the trial might deserve some clarification.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.4987
UR  - http://dx.doi.org/10.1001/jama.2012.4987
ER  -